Cases compared
AstraZeneca Pharmaceuticals LP, et al., Petitioners v. Mosaic Health, Inc., et al. vs. Nexstar Media Group, Inc. v. DirecTV, LLC vs. John H. Owoc, aka Jack Owoc v. Monster Energy Company, a Delaware Corporation
Business and Regulation cases on the Supreme Court docket, side by side.
No. 25-1070No. 25-1243No. 25-1264
Side by side
| Fact | AstraZeneca Pharmaceuticals LP, et al., Petitioners v. Mosaic Health, Inc., et al. | Nexstar Media Group, Inc. v. DirecTV, LLC | John H. Owoc, aka Jack Owoc v. Monster Energy Company, a Delaware Corporation |
|---|---|---|---|
| Docket | 25-1070 | 25-1243 | 25-1264 |
| Status | Before Arguments | Before Arguments | Dismissed |
| Date | October Term 2025 (2025–2026) | October Term 2025 (2025–2026) | October Term 2025 (2025–2026) |
| Question presented | 1. Whether Illinois Brick Co. v. Illinois, 431 U.S. 720 (1977), which bars antitrust claims by indirect purchasers and sellers, applies to a claim of “lost profit” damages based on indirect purchases or sales that were not made due to the alleged conspiracy? 2. Whether the allegation that businesses had an “opportunity to conspire,” such as through joint lobbying and participation in a trade association, plausibly suggests an antitrust conspiracy? | Whether a plaintiff has antitrust standing to recover purported downstream losses flowing from its decision not to purchase an allegedly price-fixed product? | 1. Whether a civil jury may determine the scientific validity, biochemical identity, or physiological efficacy of a patented compound — and impose nationwide prohibitions on its labeling and promotion — in the absence of any regulatory action by the Food and Drug Administration, thereby substituting judicial verdicts for Federal scientific oversight in violation of due process and the separation of powers? 2. Whether a court violates due process by excluding critical, reliable defense evidence that goes to falsity, materiality, and affirmative defenses in a Lanham Act action — thereby preventing a defendant from presenting a complete defense? 3. Whether a court violates federal antitrust law and due process by permitting litigation to proceed where the suit is objectively baseless and brought as a competitive weapon to destroy a rival, thereby stripping it of Noerr-Pennington immunity under the sham-litigation doctrine? 4. May a lay jury impose the largest civil penalty in the history of the Lanham act based on admitted guesswork and standardless damages determinations, in Violation of a Court Order prohibiting speculation, without violating due process, where the verdict operates as punishment and de facto regulatory action rather than compensation for proven harm? |
| Summary | AstraZeneca, Eli Lilly, Novo Nordisk, and Sanofi ask the Supreme Court to review a Second Circuit antitrust case brought by health-care providers. The dispute concerns whether the providers may seek lost-profit damages tied to purchases or sales they say did not occur because of an alleged drug-pricing conspiracy, and whether allegations of joint lobbying and trade-association participation plausibly show an agreement to conspire. | Nexstar Media Group asks the Supreme Court to review a Second Circuit ruling that allowed DirecTV to seek antitrust damages for claimed lost downstream revenue after it chose not to buy allegedly price-fixed television programming. The case concerns whether a business that did not purchase the allegedly overpriced product can nevertheless show the direct, non-speculative injury required for antitrust standing. | John “Jack” Owoc has asked the Supreme Court to review a Ninth Circuit case involving Monster Energy. His petition raises challenges to a civil verdict and litigation over claims about a patented compound, including whether courts may resolve scientific and labeling issues without FDA action, whether defense evidence was wrongly excluded, and whether the suit was improper anticompetitive litigation. |
Relationship
- Shared issue
- Business and Regulation
- Why compared
- Reviewed Business and Regulation tags connect these current-term public cases.
Related
Sources
- Built from reviewed issue tags and official docket records. Status lines and questions presented come from the tracked case data.